2016
Impact of Concurrent Androgen-Deprivation Therapy and Radiation Therapy Versus Radiation Therapy Alone on Overall Survival for Men With Unfavorable Intermediate-Risk Prostate Cancer
Johnson S, Lester-Coll N, Stahl J, Nath S, Yu J. Impact of Concurrent Androgen-Deprivation Therapy and Radiation Therapy Versus Radiation Therapy Alone on Overall Survival for Men With Unfavorable Intermediate-Risk Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e240. DOI: 10.1016/j.ijrobp.2016.06.1227.Peer-Reviewed Original Research
2012
The relations between age and androgen deprivation therapy use among men receiving radiation therapy for prostate cancer in the Medicare population.
Quon J, Yu J, Soulos P, Gross C. The relations between age and androgen deprivation therapy use among men receiving radiation therapy for prostate cancer in the Medicare population. Journal Of Clinical Oncology 2012, 30: e15150-e15150. DOI: 10.1200/jco.2012.30.15_suppl.e15150.Peer-Reviewed Original ResearchHigh-risk groupShort life expectancyRisk groupsProstate cancerLife expectancyNational Comprehensive Cancer Network guidelinesAndrogen deprivation therapy useConcurrent androgen deprivation therapyEnd Results-Medicare databaseAndrogen deprivation therapyLow-risk cancersExternal beam radiationLow-risk groupLonger life expectancyDeprivation therapyNCCN guidelinesOlder patientsClinical factorsTherapy useGuideline recommendationsTumor characteristicsNetwork guidelinesCancer characteristicsRadiation therapyMedicare population